CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 835 enrolled
Drug / intervention
Chlorhexidine +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02572791
NCT02572791Phase 4Completed

Integrating Personal and Household Environmental Hygiene Measures to Prevent Methicillin-Resistant Staphylococcus Aureus Infection

Washington University School of Medicine·interventional·Posted Oct 9, 2015·Updated Feb 24, 2026

In Brief

A Phase 4 clinical trial evaluating Chlorhexidine, Mupirocin, and 1 other intervention for Skin and Subcutaneous Tissue Bacterial Infections and 2 related conditions. Completed, enrolled 835 participants across 2 sites.

Detailed Summary

The investigators propose a pragmatic comparative effectiveness trial evaluating several decolonization strategies in patients with Staphylococcus aureus infection, their household contacts, and household environmental surfaces. The central hypothesis of this proposal is that an integrated approach of periodic personal and household environmental hygiene will reduce S. aureus transmission in households and subsequently decrease the incidence of skin and soft tissue infections (SSTI).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 9, 2015
Enrollment StartOct 1, 2015
Primary CompletionNov 1, 2024
Study CompletionDec 1, 2024
TodayJul 2, 2026
Enrollment to primary: 9.1 yearsPosted 10.7 years ago

Interventions

Chlorhexidinedrug

Mupirocindrug

Household cleaningbehavioral